Trials / Conditions / CLL, Refractory
CLL, Refractory
4 registered clinical trials studyying CLL, Refractory — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL NCT07342478 | Newave Pharmaceutical Inc | Phase 3 |
| Completed | REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy NCT05621148 | French Innovative Leukemia Organisation | — |
| Completed | Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia NCT04512105 | University of California, Irvine | Phase 1 |
| Terminated | A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS NCT03884829 | Cyclacel Pharmaceuticals, Inc. | Phase 1 |